Retour sur lavenir.net
   DEME GROUP 169.000 € (+0,12 %)     CELYAD ONCOLOGY 0.250 € (-9,42 %)     WDP 22.400 € (+1,36 %)     AB INBEV 72.520 € (+1,45 %)     VGP 82.700 € (+1,97 %)     FAGRON 23.700 € (-0,63 %)     ENERGYVISION 14.840 € (+0,27 %)     XIOR 27.950 € (0,00 %)     NYXOAH 1.368 € (-1,16 %)     ELIA GROUP 139.800 € (+1,60 %)     KBC 122.650 € (+0,25 %)     BPOST 1.560 € (-0,64 %)     ORANGE BELGIUM 21.800 € (+0,46 %)     TESSENDERLO 20.900 € (+1,95 %)     ECONOCOM GROUP 1.465 € (0,00 %)     COLRUYT 38.120 € (+0,47 %)     ONTEX GROUP 2.265 € (+2,49 %)     CFE 11.500 € (+0,44 %)     IBA 16.680 € (-0,36 %)     VIOHALCO 17.680 € (+2,67 %)     TEXAF 40.400 € (-2,42 %)     SHURGARD 25.550 € (+1,39 %)     KBC ANCORA 87.100 € (-0,11 %)     UCB 243.300 € (-0,25 %)     TINC 11.340 € (+1,80 %)     CIE BOIS SAUVAGE 310.000 € (+2,99 %)     FLUXYS BELGIUM D 20.000 € (+2,56 %)     SOLVAY 26.140 € (+0,62 %)     SOLVAC NOM(RETAIL) 77.500 € (+3,33 %)     PROXIMUS 6.135 € (+1,24 %)     AGFA-GEVAERT 0.400 € (+1,39 %)     GBL 77.850 € (+0,84 %)     ONWARD MEDICAL 2.475 € (-0,40 %)     SIPEF 93.900 € (+1,62 %)     ACKERMANS V.HAAREN 269.800 € (+0,45 %)     JENSEN-GROUP 85.800 € (+1,90 %)     CENERGY 21.560 € (+1,41 %)     BELYSSE GROUP 0.510 € (+6,25 %)     AGEAS 72.050 € (+1,77 %)     TUBIZE-FIN 210.000 € (+0,48 %)     VAN DE VELDE 30.100 € (+1,69 %)     HOME INVEST BE. 19.860 € (+2,06 %)     BREDERODE 103.000 € (0,00 %)     WERELDHAVE BELGIUM 53.200 € (+1,53 %)     VASTNED 29.400 € (+0,34 %)     ARGENX SE 758.400 € (-0,24 %)     AEDIFICA 70.400 € (+0,72 %)     RECTICEL 12.120 € (+0,83 %)     CAMPINE 207.000 € (+0,49 %)     AZELIS GROUP 10.480 € (-0,29 %)     ASCENCIO 51.600 € (+0,19 %)     GIMV 44.850 € (+0,67 %)     D'IETEREN GROUP 176.000 € (+2,09 %)     RETAIL ESTATES 68.500 € (+1,33 %)     EVS 27.000 € (+0,37 %)     BARCO 8.000 € (+2,63 %)     DECEUNINCK 2.190 € (+0,69 %)     SYENSQO 69.700 € (+0,58 %)     SOFINA 233.800 € (+2,01 %)     TITAN S.A. 50.700 € (+3,89 %)  
   SAFRAN 327.300 € (+1,36 %)     BNP PARIBAS ACT.A 106.780 € (+1,54 %)     PLANISWARE 20.050 € (+0,25 %)     PROSUS 37.110 € (-3,60 %)     CRCAM MORBIHAN CCI 110.000 € (-0,09 %)     ENGIE 27.560 € (+1,96 %)     SOCIETE GENERALE 78.060 € (+1,11 %)     BE SEMICONDUCTOR 248.100 € (+3,59 %)     ALFEN 13.550 € (-1,38 %)     TIKEHAU CAPITAL 17.300 € (-0,35 %)     ARTMARKET COM 2.600 € (+11,11 %)     PERNOD RICARD 63.140 € (+0,86 %)     EXOSENS 61.950 € (+2,57 %)     EUROPLASMA 0.001 € (-16,67 %)     SCHNEIDER ELECTRIC 269.000 € (+0,07 %)     ABIONYX PHARMA 1.920 € (+3,00 %)     STELLANTIS NV 5.092 € (+0,20 %)     AIR LIQUIDE 176.740 € (+0,12 %)     STMICROELECTRONICS 58.270 € (+1,78 %)     GRAINES VOLTZ 18.000 € (-0,83 %)     ASM INTERNATIONAL 895.400 € (-0,80 %)     GROUPE OKWIND 0.215 € (-10,42 %)     CROSSJECT 1.544 € (-2,03 %)     MICHELIN 35.010 € (-0,14 %)     ACCOR 46.290 € (-0,15 %)     ASML HOLDING 1 589.600 € (-0,24 %)     WOLTERS KLUWER 59.980 € (-0,03 %)     CARREFOUR 16.650 € (+0,63 %)     TOTALENERGIES 74.290 € (+2,03 %)     ING GROEP N.V. 29.215 € (+0,53 %)     CVC CAPITAL 14.300 € (-0,83 %)     ELIS 25.400 € (+0,79 %)     ADYEN 820.900 € (+0,04 %)     AKZO NOBEL 58.140 € (+1,71 %)     LVMH 474.000 € (-0,95 %)     HERMES INTL 1 679.500 € (-0,09 %)     AIRBUS 208.300 € (+7,04 %)     REXEL 38.210 € (+0,26 %)     LARGO 1.520 € (+4,11 %)     UNILEVER 54.090 € (+1,22 %)     KERING 250.750 € (-0,08 %)     CHRISTIAN DIOR 440.000 € (0,00 %)     RELX 28.880 € (-0,07 %)     RAPID NUTRITION 4.070 € (+13,69 %)     ABIVAX 115.400 € (-1,79 %)     BUREAU VERITAS 27.220 € (+0,59 %)     JCDECAUX 22.140 € (+1,28 %)     L'OREAL 380.650 € (+0,50 %)     FUGRO 9.785 € (+1,19 %)     TELEPERFORMANCE 54.260 € (+1,76 %)     QUADIENT 12.880 € (+0,94 %)     AEGON 8.074 € (+0,67 %)     GTT 192.000 € (+1,27 %)     VALEO 13.310 € (+2,11 %)     AMUNDI 87.900 € (-1,18 %)     DASSAULT SYSTEMES 17.760 € (-0,89 %)     FRANCAISE ENERGIE 27.150 € (-6,38 %)     MAGNUM 15.884 € (+0,43 %)     WORLDLINE 10.050 € (-1,08 %)     ARVERNE GROUP 8.960 € (-0,44 %)  
News Réglementées
08/07/2026 09:00

Original-Research: The NAGA Group AG (von NuWays AG): BUY

Original-Research: The NAGA Group AG - from NuWays AG

08.07.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to conclude certain stock exchange transactions.


Classification of NuWays AG to The NAGA Group AG

Company Name:The NAGA Group AG
ISIN:DE000A41YCM0
 
Reason for the research:Update
Recommendation:BUY
Target price:EUR 7.30
Target price on sight of:12 months
Last rating change:
Analyst:Simon Keller

Cost work done, growth is next, chg.

Recently, NAGA published its audited FY25 financial statements, confirming group revenues of € 62.4m (FY24: € 63.2m), broadly in line with the preliminary figures. FX-adj. revenue growth stood at 3.5% yoy, pointing to a more resilient underlying development than the reported top-line suggests. EBITDA came in at € 3.7m (FY24: € 9.0m) 12% above the preliminary figure.

The audited FY25 figures highlight progress in cost and marketing efficiency. Most relevant is the improvement in customer acquisition, with marketing spend up 15.6% yoy, new funded accounts up 37.5% and CAC down 16.5%. This links directly to the Q1 26 pattern, where a 9.7pp yoy EBITDA margin improvement was accompanied by healthier client KPIs, including higher trading volumes, stronger activity, rising net deposits and lower withdrawals. In our view, these data points suggest that the leaner setup is increasingly translating into better operating quality.

FY26 guidance remains at € 68-75m revenues and € 10-15m EBITDA. At the lower end, this implies c. 16% yoy revenue growth for the remaining nine months, requiring a visible acceleration from the Q1 run-rate. The implied EBITDA increase for the remaining nine months is c. 189% yoy, which looks demanding but is flattered by a low prior-year base. A weaker EUR could provide some tailwind to reported revenue growth over the coming quarters. Despite an encouraging Q1 exit rate, we remain conservatively below guidance with our FY26 estimates of € 64.4m revenues and € 9.0m EBITDA, pending further visibility on the sales improvement.

Separately, NAGA received a MiCA authorization from the CySEC, allowing it to provide regulated crypto-asset services across the EU under the bloc’s harmonized crypto framework. This strengthens the regulatory foundation of its crypto offering and supports the integration of digital assets into NAGA ONE, the group’s SuperApp for payments, investing and trading. Near term, the market backdrop remains less supportive, with crypto prices under pressure and volatility low by historical standards (source: Deribit), limiting trading activity and monetization. We therefore see MiCA mainly as a strategic milestone rather than an immediate earnings driver. In a more normalized crypto market, the license should help NAGA scale its crypto services in Europe.

In sum, NAGA is visibly operating with a more efficient structure, improved profitability and better client KPIs. High management ownership of c. 43% provides shareholder alignment, while ongoing product improvements, including NAGA ONE, AI-supported processes and the regulated crypto layer under MiCA, should strengthen the platform proposition. Improved revenue growth could be the next catalyst, in our view. With the cost base now more efficient, even moderate sales acceleration should translate more visibly into earnings, provided cost discipline is maintained. This leaves NAGA with a more scalable setup and a clearer path towards stronger profitability.

BUY with a PT of € 7.30 (old: € 9.50), based on an overhauled DCF, reflecting more conservative mid-term growth assumptions following analyst change.



You can download the research here: the-naga-group-ag-2026-07-08-previewreview-en-231b2
For additional information visit our website: https://www.nuways-ag.com/research

Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse.
++++++++++


The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2362124  08.07.2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière